Mesenchymal stem cells for bone gene therapy

Principles of Bone Regeneration

Volumn , Issue , 2012, Pages 81-96

  Pelled, Gadi ^a   Mizrahi, Olga ^a   Kimelman Bleich, Nadav ^a   Gazit, Dan ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; STEM CELLS;

MESENCHYMAL STEM CELL;

GENE THERAPY;

EID: 84876724200     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-2059-0_7     Document Type: Chapter

References (98)

1. Odorico JS, Kaufman DS, Thomson JA (2001) Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19(3):193-204
2. Jiang Y, Jahagirdar BN, Reinhardt RL et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41-49
3. Labat ML (2001) Stem cells and the promise of eternal youth: embryonic versus adult stem cells. Biomed Pharmacother 55(4):179-185
4. Martin JA, Buckwalter JA (2002) Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 3(5):257-264
5. Martin JA, Buckwalter JA (2002) Human chondrocyte senescence and osteoarthritis. Biorheology 39(1-2):145-152
6. Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309):71-74
7. Liu ZJ, Zhuge Y, Velazquez OC (2009) Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 106(6):984-991
8. Pittenger MF, Mackay AM, Beck SC et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147
9. Liechty KW, MacKenzie TC, Shaaban AF et al (2000) Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 6(11):1282-1286
10. Jankowski RJ, Deasy BM, Huard J (2002) Muscle-derived stem cells. Gene Ther 9(10):642-647
11. Lin G, Garcia M, Ning H et al (2008) Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17(6):1053-1063
12. Gazit D, Turgeman G, Kelley P et al (1999) Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1(2):121-133
13. Lieberman JR, Le LQ, Wu L et al (1998) Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 16(3):330-339
14. Lou J, Xu F, Merkel K, Manske P (1999) Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 17(1):43-50
15. Engstrand T, Daluiski A, Bahamonde ME, Melhus H, Lyons KM (2000) Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Hum Gene Ther 11(1):205-211
16. Lieberman JR, Daluiski A, Stevenson S et al (1999) The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81(7):905-917
17. Hasharoni A, Zilberman Y, Turgeman G, Helm GA, Liebergall M, Gazit D (2005) Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenetic protein-2. J Neurosurg Spine 3(1):47-52
18. Wozney JM (2002) Overview of bone morphogenetic proteins. Spine 27(16):S2-S8
19. Ebara S, Nakayama K (2002) Mechanism for the action of bone morphogenetic proteins and regulation of their activity. Spine 27(16):10-15
20. Yamaguchi A, Ishizuya T, Kintou N et al (1996) Effects of BMP-2, BMP-4, and BMP-6 on osteoblastic differentiation of bone marrow-derived stromal cell lines, ST2 and MC3T3-G2/PA6. Biochem Biophys Res Commun 220(2):366-371
21. Wang EA, Rosen V, D’Alessandro JS et al (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87(6):2220-2224
22. Volek-Smith H, Urist MR (1996) Recombinant human bone morphogenetic protein (rhBMP) induced heterotopic bone development in vivo and in vitro. Proc Soc Exp Biol Med 211(3):265-272
23. Hanada K, Dennis JE, Caplan AI (1997) Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J Bone Miner Res 12(10):1606-1614
24. Gori F, Thomas T, Hicok KC, Spelsberg TC, Riggs BL (1999) Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation. J Bone Miner Res 14(9):1522-1535
25. Fromigue O, Marie PJ, Lomri A (1998) Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68(4):411-426
26. Chaudhari A, Ron E, Rethman MP (1997) Recombinant human bone morphogenetic protein-2 stimulates differentiation in primary cultures of fetal rat calvarial osteoblasts. Mol Cell Biochem 167(1):31-39
27. Wozney JM, Rosen V, Celeste AJ et al (1988) Novel regulators of bone formation: molecular clones and activities. Science 242(4885):1528-1534
28. Lecanda F, Avioli LV, Cheng SL (1997) Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J Cell Biochem 67(3):386-396
29. Steinhardt Y, Aslan H, Regev E et al (2008) Maxillofacial-derived stem cells regenerate critical mandibular bone defect. Tissue Eng Part A 14(11):1763-1773
30. Kirker-Head C, Karageorgiou V, Hofmann S et al (2007) BMP-silk composite matrices heal critically sized femoral defects. Bone 41(2):247-255
31. Wright V, Peng H, Usas A et al (2002) BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. Mol Ther 6(2): 169-178
32. Peng H, Wright V, Usas A et al (2002) Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110(6): 751-759
33. Gysin R, Wergedal JE, Sheng MH et al (2002) Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Ther 9(15):991-999
34. Dumont RJ, Dayoub H, Li JZ et al (2002) Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 51(5):1239-1244, 1244-1235
35. Chen Y, Cheung KM, Kung HF, Leong JC, Lu WW, Luk KD (2002) In vivo new bone formation by direct transfer of adenoviral-mediated bone morphogenetic protein-4 gene. Biochem Biophys Res Commun 298(1):121-127
36. Valdes M, Moore DC, Palumbo M et al (2007) RhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit. Spine J 7(3):318-325
37. Yoon ST, Boden SD (2002) Osteoinductive molecules in orthopaedics: basic science and preclinical studies. Clin Orthop Relat Res 395:33-43
38. Valentin-Opran A, Wozney J, Csimma C, Lilly L, Riedel GE (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395:110-120
39. Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31(6):721-727
40. Moutsatsos IK, Turgeman G, Zhou S et al (2001) Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 3(4):449-461
41. Turgeman G, Pittman DD, Muller R et al (2001) Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3(3):240-251
42. Oreffo RO, Virdi AS, Triffitt JT (2001) Retroviral marking ofhuman bone marrow fibroblasts: in vitro expansion and localization in calvarial sites after subcutaneous transplantation in vivo. J Cell Physiol 186(2):201-209
43. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S (1998) Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16 (2): 15 5-16 2
44. Mankani MH, Kuznetsov SA, Fowler B, Kingman A, Robey PG (2001) In vivo bone formation by human bone marrow stromal cells: effect of carrier particle size and shape. Biotechnol Bioeng 72(1):96-107
45. Laurencin CT, Attawia MA, Lu LQ et al (2001) Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. Biomaterials 22(11):1271-1277
46. Young BH, Peng H, Huard J (2002) Muscle-based gene therapy and tissue engineering to improve bone healing. Clin Orthop Relat Res 403:S243-S251
47. Skillington J, Choy L, Derynck R (2002) Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes. J Cell Biol 159(1): 13 5-146
48. Peterson B, Zhang J, Iglesias R et al (2005) Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11(1): 120-129
49. Musgrave DS, Pruchnic R, Bosch P, Ziran BH, Whalen J, Huard J (2002) Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2. J Bone Joint Surg Br 84(1):120-127
50. Lee JY, Musgrave D, Pelinkovic D et al (2001) Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 83-65(7): 1032-1039
51. Dragoo JL, Choi JY, Lieberman JR et al (2003) Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 21(4):622-629
52. De Ugarte DA, Morizono K, Elbarbary A et al (2003) Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174(3):101-109
53. Usas A, Ho AM, Cooper GM, Olshanski A, Peng H, Huard J (2008) Bone regeneration mediated by BMP4-expressing muscle-derived stem cells is affected by delivery system. Tissue Eng Part A 15(2):285-293
54. Knippenberg M, Helder MN, Doulabi BZ, Bank RA, Wuisman PI, Klein-Nulend J (2009) Differential effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of collagen-modifying enzymes in human adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A 15(8):2213-2225
55. Hsu WK, Wang JC, Liu NQ et al (2008) Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am 90(5):1043-1052
56. Wobus AM, Boheler KR (1999) Embryonic Stem Cells as Developmental Model in vitro. Preface. Cells Tissues Organs 165(3):129-130
57. Phillips BW, Belmonte N, Vernochet C, Ailhaud G, Dani C (2001) Compactin enhances osteogenesis in murine embryonic stem cells. Biochem Biophys Res Commun 284(2):478-484
58. Karner E, Unger C, Sloan AJ, Ahrlund-Richter L, Sugars RV, Wendel M (2007) Bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro. Stem Cells Dev 16(1):39&—52
59. Robertson JA (2001) Human embryonic stem cell research: ethical and legal issues. Nat Rev Genet 2(1):74-78
60. Scott CT (2008) Stem cells: new frontiers of ethics, law, and policy. Neurosurg Focus 24(3-4):E24
61. Jiang Y, Vaessen B, Lenvik T, Blackstad M, Reyes M, Verfaillie CM (2002) Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30(8):896-904
62. Kempen DH, Lu L, Heijink A etal (2009) Effect oflocal sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30(14):2816-2825
63. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5(6):623-628
64. Yang X, Castilla LH, Xu X et al (1999) Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 126(8):1571-1580
65. Yamashita H, Shimizu A, Kato M et al (1997) Growth/differentiation factor-5 induces angiogenesis in vivo. Exp Cell Res 235(1):218-226
66. David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20(3):203-212
67. Peng H, Usas A, Olshanski A et al (2005) VEGF improves, whereas sFlt1 inhibits, BMP2- induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20(11):2017-2027
68. Notelovitz M (1997) Estrogen therapy and osteoporosis: principles & practice. Am J Med Sci 313(1):2&—12
69. Kassem M, Melton LJ, Riggs BL (1996) The type I/type II model for involutional osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic, New York, pp 691-702
70. Turgeman G, Zilberman Y, Zhou S et al (2002) Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 86(3):461-474
71. Gazit D, Zilberman Y, Turgeman G, Zhou S, Kahn A (1999) Recombinant TGF-beta1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice. J Cell Biochem 73(3):379-389
72. Gazit D, Zilberman Y, Ebner R, Kahn A (1998) Bone loss (osteopenia) in old male mice results from diminished activity and availability of TGF-beta. J Cell Biochem 70(4):478-488
73. Byers RJ, Hoyland JA, Braidman IP (2001) Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 168(3):353-362
74. Bellantuono I, Aldahmash A, Kassem M (2009) Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta 1792(4):364-370
75. Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D (2001) Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl 36 (Suppl):144-155
76. Goater JJ, O&’Keefe RJ, Rosier RN, Puzas JE, Schwarz EM (2002) Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis. J Orthop Res 20(2):169-173
77. Yudoh K, Matsuno H, Nakazawa F, Katayama R, Kimura T (2001) Reconstituting telomerase activity using the telomerase catalytic subunit prevents the telomere shorting and replicative senescence in human osteoblasts. J Bone Miner Res 16(8):1453-1464
78. Murray J (1999) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott Williams & Wilkins, Philadelphia
79. Abboud SL, Woodruff K, Liu C, Shen V, Ghosh-Choudhury N (2002) Rescue of the osteo- petrotic defect in op/op mice by osteoblast-specific targeting of soluble colony-stimulating factor-1. Endocrinology 143(5):1942-1949
80. Niyibizi C, Smith P, Mi Z, Phillips CL, Robbins P (2001) Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. J Cell Biochem 83(1):84&—91
81. Kuhlcke K, Fehse B, Schilz A et al (2002) Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels. Mol Ther 5(4):473-478
82. Sugiyama O, An DS, Kung SP et al (2005) Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol Ther 11(3):390-398
83. Miyazaki M, Sugiyama O, Zou J et al (2008) Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Phila Pa 1976) 33(13):1410-1417
84. Liu P, Kalajzic I, Stover ML, Rowe DW, Lichtler AC (2001) Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation. Bone 29(4):331-335
85. Kalajzic I, Stover ML, Liu P, Kalajzic Z, Rowe DW, Lichtler AC (2001) Use of VSV-G pseudo- typed retroviral vectors to target murine osteoprogenitor cells. Virology 284(1):37-45
86. Ricks DM, Kutner R, Zhang XY, Welsh DA, Reiser J (2008) Optimized lentiviral transduction of mouse bone marrow-derived mesenchymal stem cells. Stem Cells Dev 17(3):441-450
87. Peng H, Chen ST, Wergedal JE et al (2001) Development of an MFG-based retroviral vector system for secretion of high levels of functionally active human BMP4. Mol Ther 4(2):95-104
88. Stover ML, Wang CK, McKinstry MB et al (2001) Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice. Mol Ther 3(4):543-550
89. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG (2001) Circulating skeletal stem cells. J Cell Biol 153(5):1133-1140
90. Viggeswarapu M, Boden SD, Liu Y et al (2001) Adenoviral delivery of LIM mineralization protein-1 induces new-bone formation in vitro and in vivo. J Bone Joint Surg Am 83-A(3):364-376
91. Varady P, Li JZ, Cunningham M et al (2001) Morphologic analysis of BMP-9 gene therapy- induced osteogenesis. Hum Gene Ther 12(6):697-710
92. Griffith CK, Miller C, Sainson RC et al (2005) Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11(1):257-266
93. Bouchentouf M, Benabdallah BF, Bigey P, Yau TM, Scherman D, Tremblay JP (2008) Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 15(6):404-414
94. Potier E, Ferreira E, Andriamanalijaona R et al (2007) Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40(4):1078-1087
95. Fang TD, Salim A, Xia W et al (2005) Angiogenesis is required for successful bone induction during distraction osteogenesis. J Bone Miner Res 20(7):1114-1124
96. Riess JG (2006) Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol 34(6):567-580
97. Lowe KC, Davey MR, Power JB (1998) Perfluorochemicals: their applications and benefits to cell culture. Trends Biotechnol 16(6):272-277
98. Kimelman-Bleich N, Pelled G, Sheyn D et al (2009) The use of a synthetic oxygen carrier- enriched hydrogel to enhance mesenchymal stem cell-based bone formation in vivo. Biomaterials 30(27):4639-4648